Feto-Endoscopic Tracheal Occlusion (FETO) for Left Congenital Diaphragmatic Hernia

Description

Tracheal occlusion IDE approved by FDA for congenital diaphragmatic hernia fetuses.

Conditions

Congenital Diaphragmatic Hernia, Pulmonary Hypoplasia, Pulmonary; Hypertension

Study Overview

Study Details

Study overview

Tracheal occlusion IDE approved by FDA for congenital diaphragmatic hernia fetuses.

Feto-Endoscopic Tracheal Occlusion (FETO) for Left Congenital Diaphragmatic Hernia

Feto-Endoscopic Tracheal Occlusion (FETO) for Left Congenital Diaphragmatic Hernia

Condition
Congenital Diaphragmatic Hernia
Intervention / Treatment

-

Contacts and Locations

Cincinnati

Cincinnati Children's Hospital Medical Center (CCHMC), Cincinnati, Ohio, United States, 45229

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Isolated CDH with liver up
  • * Severe pulmonary hypoplasia with ultrasound O/E LHR \<25% at the time of surgery
  • * Gestational age at FETO procedure 27 weeks 0 days to 29 weeks 6 days
  • * Moderate pulmonary hypoplasia with ultrasound O/E LHR \<30% and liver-up at the time of surgery
  • * Gestational age at FETO procedure 30 weeks 0 days to 31 weeks 6 days in this moderate category
  • * Maternal age greater than or equal to 18 years
  • * Gestational age at enrollment prior to 29 weeks 6 days, or 31 weeks 6 days in moderate category
  • * Normal karyotype or FISH
  • * Normal fetal echocardiogram
  • * Singleton pregnancy
  • * Willing to remain in the greater Cincinnati area for remainder of pregnancy
  • * Family considered and decline option of termination of the pregnancy at less than 24 weeks 0 days
  • * Family meets psychosocial criteria
  • * Patient \< 18 years old
  • * Multi-fetal pregnancy
  • * Rubber latex allergy
  • * Preterm labor, cervix shortened (\<15 mm) or uterine anomaly strongly predisposing to preterm labor, placenta previa
  • * Bilateral CDH, isolated left sided CDH with an O/E \> 30%
  • * Additional fetal anomaly by ultrasound, MRI, or echocardiogram
  • * Chromosomal abnormalities
  • * Maternal contraindications to fetoscopic surgery or severe maternal condition in pregnancy
  • * Incompetent cervix with or without a cerclage
  • * Placental abnormalities known at time of enrollment
  • * Maternal HIV, Hepatits B, Hepatitis C
  • * Maternal uterine anomaly
  • * No safe or technically feasible fetoscopic approach to balloon placement
  • * Participation in another intervention study that influences maternal and fetal morbidity and mortality or participation in this trial in a previous pregnancy

Ages Eligible for Study

18 Years to 50 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Children's Hospital Medical Center, Cincinnati,

Kurt Schibler, MD, STUDY_CHAIR, CCHMC Oversight Data Safety Monitoring Committee

Study Record Dates

2026-12